Glycosylation is an important product quality attribute for biotherapeutic proteins expressed in CHO cells. Glycoform variability can significantly affect the safety and efficacy of therapeutic proteins, and can be dependent on several factors, including cell line, media/feeds, and process. As a consequence, it has often been challenging to achieve and maintain preferred glycosylation profiles from cell culture development through bioreactor scale-up. To address these challenges, we have developed a new feed technology in conjunction with a unique fed-batch process that together has been shown not only to maximize protein titers but also to modulate glycan profiles.
Biotechnology
Microbiology
Cancer Research
Molecular Biology
Antibodies
Neuroscience
Cancer Therapeutics
University
Biochemistry
Pcr/rt-Pcr/real-Time Pcr
Dna
Research
Research And Development
Cell Culture
Immunology
North America45%
Asia30%
South America15%
Europe6%
Africa3%
Website Visitors100%
Student32%
Research Scientist21%
Executive7%
Facility/Department Manager7%
Scientist7%
Lab Management7%
Medical Doctor/Specialist4%
Genetic Counselor4%
Medical Laboratory Technician4%
Educator/Faculty4%
Pharmacist4%
Academic Institution21%
Biotech Company9%
Life Science Company6%
Research Institute3%
Pharmaceutical Company3%
Manufacturer - Other3%
Government3%
Clinical Laboratory3%
Other6%